Article Versions Notes

Kim T-Y, Kwag D, Lee J-H, Lee J, Min G-J, Park S-S, Park S, Jeon Y-W, Yoon J-H, Shin S-H, et al. Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients. Cancers. 2022; 14(18):4485. https://doi.org/10.3390/cancers14184485

Kim, Tong-Yoon, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung-Soo Park, Silvia Park, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hawn Shin, and et al. 2022. "Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients" Cancers 14, no. 18: 4485. https://doi.org/10.3390/cancers14184485

Kim, T.-Y., Kwag, D., Lee, J.-H., Lee, J., Min, G.-J., Park, S.-S., Park, S., Jeon, Y.-W., Yoon, J.-H., Shin, S.-H., Yahng, S.-A., Cho, B.-S., Eom, K.-S., Kim, Y.-J., Lee, S., Kim, H.-J., Min, C.-K., Cho, S.-G., Lee, J.-W., ... Lee, S.-E. (2022). Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients. Cancers, 14(18), 4485. https://doi.org/10.3390/cancers14184485